Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Massachusetts General Hospital is evaluating spironolactone to improve trajectories in pregnancy-associated hypertension a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Preeclampsia, Gestational Hypertension | Phase 2 | Status: RECRUITING